The Board of Directors of Zhejiang Hisoar Pharmaceutical Co., Ltd. has authorized a buyback plan on February 2, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.31 CNY | -0.47% | -2.02% | -12.24% |
04-28 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.24% | 1.39B | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Zhejiang Hisoar Pharmaceutical Co., Ltd. authorizes a Buyback Plan.